These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 37925109
1. Clinical significance of mutations in dihydropteroate synthase in Pneumocystis jirovecii pneumonia among non-HIV-infected patients. Liao TY, Huang YT, Lee TF, Hsueh PR, Yu CJ, Chien JY. Int J Antimicrob Agents; 2024 Jan; 63(1):107019. PubMed ID: 37925109 [Abstract] [Full Text] [Related]
2. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy. Ponce CA, Chabé M, George C, Cárdenas A, Durán L, Guerrero J, Bustamante R, Matos O, Huang L, Miller RF, Vargas SL. Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855071 [Abstract] [Full Text] [Related]
3. Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia. Tyagi AK, Mirdha BR, Luthra K, Guleria R, Mohan A, Singh UB, Samantaray JC, Dar L, Iyer VK, Chaudhry R. J Infect Dev Ctries; 2010 Nov 24; 4(11):761-6. PubMed ID: 21252456 [Abstract] [Full Text] [Related]
4. Novel dihydropteroate synthase gene mutation in Pneumocystis jirovecii among HIV-infected patients in India: Putative association with drug resistance and mortality. Singh Y, Mirdha BR, Guleria R, Kabra SK, Mohan A, Chaudhry R, Kumar L, Dwivedi SN, Agarwal SK. J Glob Antimicrob Resist; 2019 Jun 24; 17():236-239. PubMed ID: 30658203 [Abstract] [Full Text] [Related]
5. Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort. Suárez I, Roderus L, van Gumpel E, Jung N, Lehmann C, Fätkenheuer G, Hartmann P, Plum G, Rybniker J. Infection; 2017 Jun 24; 45(3):341-347. PubMed ID: 28303545 [Abstract] [Full Text] [Related]
6. Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia. Rabodonirina M, Vaillant L, Taffé P, Nahimana A, Gillibert RP, Vanhems P, Hauser PM. Emerg Infect Dis; 2013 Jan 24; 19(1):21-8; quiz 186. PubMed ID: 23260763 [Abstract] [Full Text] [Related]
7. Molecular Analysis of Dihydropteroate Synthase Gene Mutations in Pneumocystis jirovecii Isolates among Bulgarian Patients with Pneumocystis Pneumonia. Tsvetkova N, Harizanov R, Rainova I, Ivanova A, Yancheva-Petrova N. Int J Mol Sci; 2023 Nov 29; 24(23):. PubMed ID: 38069248 [Abstract] [Full Text] [Related]
8. Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients. Alvarez-Martínez MJ, Miró JM, Valls ME, Mas J, de la Bellacasa JP, Sued O, Solé M, Rivas PV, de Lazzari E, Benito N, García F, Agustí C, Wilson PE, Gatell JM, Jiménez de Anta MT, Meshnick SR, Moreno A. Diagn Microbiol Infect Dis; 2010 Sep 29; 68(1):60-5. PubMed ID: 20727472 [Abstract] [Full Text] [Related]
9. Clinical characteristics and prevalence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii-infected AIDS patients from low endemic areas of China. Zhu M, Ye N, Xu J. PLoS One; 2020 Sep 29; 15(9):e0238184. PubMed ID: 32911508 [Abstract] [Full Text] [Related]